Tardive Dyskinesia Treatment Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disorder (Bradykinesia, Hyperkinesia); Drug Class (Dopamine-Depleting Medications, VMAT2 Inhibitors, GABA Receptor Agonist Medications, Anticholinergic Medications Trihexyphenidyl); End User (Hospitals, Clinical, Others) , and Geography (North America, Europe, Asia Pacific, and South and Central America)